Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery

Tissue Engineering - Part A

Volumn 20, Issue 11-12, 2014, Pages 1726-1734

  Syedain, Zeeshan H ^a   Meier, Lee A ^a   Lahti, Mathew T ^b   Johnson, Sandra L ^a   Tranquillo, Robert T ^a,b  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOTECHNOLOGY;

BIOLOGICAL GRAFTS; BURST PRESSURES; CIRCUMFERENTIAL ALIGNMENT; DECELLULARIZATION; DERMAL FIBROBLASTS; ENDOTHELIALIZATION; GRAFT PROPERTIES; RECELLULARIZATION;

CELL CULTURE;

ELASTIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANISOTROPY; ANTICOAGULANT THERAPY; ARTERIAL CIRCULATION; ARTICLE; BIOENGINEERING; CALCIFICATION; CONTROLLED STUDY; DILATATION; ECHOGRAPHY; FEMORAL ARTERY; FIBROBLAST; HYPERPLASIA; IMPLANTATION; IN VITRO STUDY; MINERALIZATION; NONHUMAN; PRIORITY JOURNAL; SHEEP; THROMBOGENICITY; ANIMAL; BIOMECHANICS; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; ENDOTHELIUM; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; PHYSIOLOGY; PROCEDURES; PROSTHESIS IMPLANTATION; RADIOGRAPHY; TISSUE ENGINEERING;

ANIMALS; BIOMECHANICAL PHENOMENA; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; ENDOTHELIUM; FEMORAL ARTERY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; PROSTHESIS IMPLANTATION; SHEEP; TISSUE ENGINEERING;

EID: 84901217965     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0550     Document Type: Article

References (36)

1. Conte, M.S. The ideal small arterial substitute: a search for the Holy Grail? FASEB J 12, 43, 1998.
2. Kannan, R.Y., Salacinski, H.J., Butler, P.E., Hamilton, G., and Seifalian, A.M. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res Part B Appl Biomater 74, 570, 2005.
3. Peck, M., Gebhart, D., Dusserre, N., McAllister, T.N., and L'Heureux, N. The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs 195, 144, 2012.
4. Niklason, L.E., Gao, J., Abbott, W.M., Hirschi, K.K., Houser, S., Marini, R., et al. Functional arteries grown in vitro. Science 284, 489, 1999.
5. L'Heureux, N., Paquet, S., Labbe, R., Germain, L., and Auger, F.A. A completely biological tissue-engineered human blood vessel. FASEB J 12, 47, 1998.
6. Dahl, S.L., Kypson, A.P., Lawson, J.H., Blum, J.L., Strader, J.T., Li, Y., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 3, 68ra9. 2011.
7. L'Heureux, N., McAllister, T.N., and de la Fuente, L.M. Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med 357, 1451, 2007.
8. L'Heureux, N., Dusserre, N., Konig, G., Victor, B., Keire, P., Wight, T.N., et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 12, 361, 2006.
9. Quint, C., Kondo, Y., Manson, R.J., Lawson, J.H., Dardik, A., and Niklason, L.E. Decellularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci U S A 108, 9214, 2011.
10. Wystrychowski, W., McAllister, T.N., Zagalski, K., Dusserre, N., Cierpka, L., and L'Heureux, N. First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access. J Vasc Surg pii:S0741-5214(13)01530- 9, 2013.
11. Grassl, E.D., Oegema, T.R., and Tranquillo, R.T. Fibrin as an alternative biopolymer to type-I collagen for the fabrication of amedia equivalent. J BiomedMater Res 60, 607, 2002.
12. Gleason, R.L., Wilson, E., and Humphrey, J.D. Biaxial biomechanical adaptations of mouse carotid arteries cultured at altered axial extension. J Biomech 40, 766, 2007.
13. Syedain, Z.H., Meier, L.A., Bjork, J.W., Lee, A., and Tranquillo, R.T. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 32, 714, 2011.
14. Gallegos, R.P., Nockel, P.J., Rivard, A.L., and Bianco, R.W. The current state of in-vivo pre-clinical animal models for heart valve evaluation. J Heart Valve Dis 14, 423, 2005.
15. Byrom, M.J., Bannon, P.G., White, G.H., and Ng, M.K. Animal models for the assessment of novel vascular conduits. J Vasc Surg 52, 176, 2010.
16. Syedain, Z.H., Meier, L.A., Lahti, M.T., Bianco, R.W., Kren, S., Taylor, D.A., and Tranquillo, R.T. In vivo remodeling of fibrin-based tissue-engineered arterial grafts. Regenerative Medicine: Innovations for Clinical Applications. Hilton Head, SC, 2012.
17. Bjork, J.W., Meier, L.A., Johnson, S.L., Syedain, Z.H., and Tranquillo, R.T. Hypoxic culture and insulin yield improvements to fibrin-based engineered tissue. Tissue Eng Part A 18, 785, 2012.
18. Stegemann, H., and Stalder K. Determination of hydroxyproline. Clin Chim Acta 18, 267, 1967.
19. Starcher, B.C., and Galione, M.J. Purification and comparison of elastins from different animal species. Anal Biochem 74, 441, 1976.
20. Kim, Y.J., Sah, R.L., Doong, J.Y., and Grodzinsky, A.J. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174, 168, 1988.
21. Bjork, J.W., Johnson, S.L., and Tranquillo, R.T. Ruthenium- catalyzed photo cross-linking of fibrin-based engineered tissue. Biomaterials 32, 2479, 2011.
22. McAllister, T.N., Dusserre, N., Maruszewski, M., and L'Heureux, N. Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole? Regen Med 3, 925, 2008.
23. Lehr, E.J., Rayat, G.R., Chiu, B., Churchill, T., McGann, L.E., Coe, J.Y., et al. Decellularization reduces immunogenicity of sheep pulmonary artery vascular patches. J Thorac Cardiovasc Surg 141, 1056, 2011.
24. Muratov, R., Britikov, D., Sachkov, A., Akatov, V., Soloviev, V., Fadeeva, I., et al. New approach to reduce allograft tissue immunogenicity. Experimental data. Interact Cardiovasc Thorac Surg 10, 408, 2010.
25. Weinberg, C.B., and Bell, E. A blood vessel model constructed from collagen and cultured vascular cells. Science 231, 397, 1986.
26. Gilbert, T.W., Sellaro, T.L., and Badylak, S.F. Decellularization of tissues and organs. Biomaterials 27, 3675, 2006.
27. Ott, H.C., Matthiesen, T.S., Goh, S.K., Black, L.D., Kren, S.M., Netoff, T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14, 213, 2008.
28. Gui, L., Chan, S.A., Breuer, C.K., and Niklason, L.E. Novel utilization of serum in tissue decellularization. Tissue Eng Part C Methods 16, 173, 2010.
29. Quan, T.E., Cowper, S.E., and Bucala R. The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 8, 145, 2006.
30. Piera-Velazquez, S., Li, Z., and Jimenez, S.A. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 179, 1074, 2011.
31. Hibino, N., Yi, T., Duncan, D.R., Rathore, A., Dean, E., Naito, Y., et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissueengineered vascular grafts. FASEB J 25, 4253, 2011.
32. Roh, J.D., Sawh-Martinez, R., Brennan, M.P., Jay, S.M., Devine, L., Rao, D.A., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation- mediated process of vascular remodeling. Proc Natl Acad Sci U S A 107, 4669, 2010.
33. Meier, L.A., Syedain, Z.H., Lahti, M.T., Johnson, S.S., Chen, M.H., Hebbel, R.P., et al. Blood outgrowth endothelial cells alter remodeling of completely biological engineered grafts implanted into the sheep femoral artery. J Cardiovasc Transl Res 2014 [Epub ahead of print]; DOI: 10.1007/s12265-013- 9539-z.
34. JD, H. Cardiovascular Solid Mechanics: Cells, Tissues, and Organs. New York: Springer-Verlag, 2002.
35. Barocas, V.H., Girton, T.S., and Tranquillo, R.T. Engineered alignment in media equivalents: magnetic prealignment and mandrel compaction. J Biomech Eng 120, 660, 1998.
36. L'Heureux, N., Germain, L., Labbe, R., and Auger, F.A. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J Vasc Surg 17, 499, 1993.